AMD's Ryzen AI Max chips came as a huge surprise at CES 2025. They're basically super-powered versions of the company's Ryzen ...

Chip maker AMD is investing $20 million in AI drug startup Absci, which will use AMD chips and software for drug development.

Good morning. Joe Biden takes one final stand to limit AI chip exports. Apple loses its latest plea to keep iPhones in ...

President Joe Biden’s administration plans one additional round of restrictions on the export of artificial intelligence ...

The $20 million deal gives the chip supplier a toehold in the life-sciences market, a strategy it plans to replicate in other ...

Key Takeaways Advanced Micro Devices shares fell Wednesday after a double downgrade by analysts at HSBC to "reduce" from "buy ...

AI drug creation company Absci Corporation (NASDAQ:ABSI) shares are trading higher in premarket on Wednesday after the ...

HSBC just hit the brakes on the chipmaker, downgrading the stock from Buy to Reduce and slashing its price target from $200 to $110a move that signals a rocky road ahead. HSBC analyst Frank Lee didn't ...

Absci will use AMD’s $20 million investment to enhance its AI models. In parallel, the companies will collaborate to develop ...

Failed to fetch dynamically imported module: https://finance.yahoo.com/assets/_app/immutable/nodes/97.BYxs733P.js ...

Advanced Micro Devices lags Nvidia in AI design wins, prompting a downgrade to sell. See why AMD stock faces little room to ...

ASUS announces a significant expansion of its innovative Copilot+ PC lineup at CES 2025, the fastest, most intelligent ...